title: Cyclopentenone-containing oxidized phospholipids and their isoprostanes as pro-resolving mediators of inflammation.
abstract: Inflammation represents a powerful innate immune response that defends tissue homeostasis. However, the appropriate termination of inflammatory processes is essential to prevent the development of chronic inflammatory disorders. The resolution of inflammation is actively induced by specialized pro-resolving lipid mediators, which include eicosanoids, resolvins, protectins and maresins. The responsible pro-resolution pathways have emerged as promising targets for anti-inflammatory therapies since they mitigate excessive inflammation without compromising the anti-microbial defenses of the host. We have recently shown that the lipid peroxidation of membrane phospholipids, which is associated with inflammatory conditions, generates oxidized phospholipid (OxPL) species with potent pro-resolving activities. These pro-resolving OxPLs contain a cyclopentenone as their common determinant, and are structurally and functionally related to endogenous pro-resolving prostaglandins. Here, we review the regulation of inflammatory responses by OxPLs with particular focus on the bioactivities and structural characteristics of cyclopentenone-OxPLs, and discuss the impact of the responsible signaling pathways on inflammatory diseases. This article is part of a Special Issue entitled: Lipid modification and lipid peroxidation products in innate immunity and inflammation edited by Christoph J. Binder.
authors.affiliation: Institute of Pathology, University of Bern, CH-3010 Bern, Switzerland.
authors.forename: Olivier
authors.initials: O
authors.lastname: Friedli
authors.affiliation: Institute of Pathology, University of Bern, CH-3010 Bern, Switzerland. Electronic address: stefan.freigang@pathology.unibe.ch.
authors.forename: Stefan
authors.initials: S
authors.lastname: Freigang
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use; D003517:Cyclopentanes / Q000494:pharmacology*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D018836:Inflammation Mediators / Q000494:pharmacology* / Q000627:therapeutic use; D028421:Isoprostanes / Q000494:pharmacology*; D010087:Oxides / Q000494:pharmacology*; D010743:Phospholipids / Q000494:pharmacology*
chemical_list: D000893:Anti-Inflammatory Agents; D003517:Cyclopentanes; D018836:Inflammation Mediators; D028421:Isoprostanes; D010087:Oxides; D010743:Phospholipids; C013905:cyclopentenone
keywords: Cyclopentenone; Inflammation; Isoprostane; Nrf2; Oxidized phospholipid; Resolution